US$ 23.67
examples of glp 1 receptor agonists GLP-1 for individualized treatment type 2 diabetes mellitus Mapping the effectiveness and risks
Description
Associating GLP- 1 or glucagon receptor agonists with core hormones like estrogens, thyroid hormones, and dexamethasone was the strategy employed (reviewed in [137, 138])

Despite its overall favorable safety profile, certain adverse reaction risks warrant attention
DOI: Published online: July 1, 2025 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea Corresponding author: Hye Jin Yoo Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited

The most obvious symptoms of PD in the early stages are tremor, limb stiffness, decreased motor function and abnormal gait
